Flexion
8
Osteoarthritis pain project questions
1: Is the product much better than the existing products?
•The product will be the best osteoarthritis pain therapy: efficacious, safer (with minimal HPA
axis suppression and hyperglycemia) and long action
2: Can you find and market the product to the users of the product?
•About 21.2% of all adults, or 53.2m people in US, have arthritis. Market size is >billions.
3: Is the market growing?
•According to multiple sources, CABG at high digit %.
4: Is the product defendable?
•Yes, new NCE. Patent has been drafted.
5: Can you get the team, knowledge and capital to build the product?
•Yes, the path has been paved, but before IPO , it may require $40-50m to go through clinical
phases 1-2a